Literature DB >> 36223042

A need to tailor surveillance based on family history: describing a highly penetrant familial paraganglioma kindred with an SDHD pathogenic variant.

Madeline Foley1, Anu Sharma2, Kinley Garfield3, Luke Maese4, Luke Buchmann5, Julie Boyle6, Wendy Kohlmann3, Joanne Jeter7, Samantha Greenberg8.   

Abstract

Pathogenic variants (PVs) in the SDHD gene increase risk for paragangliomas (PGL)/pheochromocytomas, renal cell carcinomas, and gastrointestinal stromal tumors. Penetrance in individuals with SDHD PVs varies in reported research from 40-70%, and there is limited evidence of specific genotype risks. This study aims to characterize a multi-generational family with SDHD p.Trp43* PVs and potential genotype-phenotype considerations for surveillance. Individuals with a paternally inherited SDHD p.Trp43*(c.129G > A) PV were identified. Genetic, medical and family histories were abstracted, including clinical characteristics, tumor histories, and treatment approaches. Eleven individuals with the SDHD PV in the same kindred were diagnosed with 41 SDHx-related tumors across all family members. Eight individuals developed 27 head and neck PGL of varying origins, and seven individuals developed tumors outside of the head and neck region. Many individuals had multiple tumors, and age of first tumor diagnosis ranged from age 10 to age 45 years old. Individuals with SDHD p.Trp43* variants may have higher risks for SDHx related tumors than other SDHD variants. Prioritizing identification of at-risk individuals and initiating surveillance tailored to family history is recommended given the rate of multiple tumors found in one familial branch of individuals under 18 years old. Individuals with strong family histories of PGL at young ages with this PV will benefit from tailored surveillance recommendations.
© 2022. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  Genetics; Germline mutation; Pheochromocytoma; SDHx; Succinate dehydrogenase; Tumor predisposition

Year:  2022        PMID: 36223042     DOI: 10.1007/s10689-022-00318-9

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.446


  14 in total

1.  Rapid-sequence MRI for long-term surveillance for paraganglioma and phaeochromocytoma in patients with succinate dehydrogenase mutations.

Authors:  Eleni Daniel; Robert Jones; Matthew Bull; John Newell-Price
Journal:  Eur J Endocrinol       Date:  2016-09-15       Impact factor: 6.664

Review 2.  Von Hippel-Lindau and Hereditary Pheochromocytoma/Paraganglioma Syndromes: Clinical Features, Genetics, and Surveillance Recommendations in Childhood.

Authors:  Surya P Rednam; Ayelet Erez; Harriet Druker; Katherine A Janeway; Junne Kamihara; Wendy K Kohlmann; Katherine L Nathanson; Lisa J States; Gail E Tomlinson; Anita Villani; Stephan D Voss; Joshua D Schiffman; Jonathan D Wasserman
Journal:  Clin Cancer Res       Date:  2017-06-15       Impact factor: 12.531

3.  Clinical presentation and penetrance of pheochromocytoma/paraganglioma syndromes.

Authors:  Diana E Benn; Anne-Paule Gimenez-Roqueplo; Jennifer R Reilly; Jérôme Bertherat; John Burgess; Karen Byth; Michael Croxson; Patricia L M Dahia; Marianne Elston; Oliver Gimm; David Henley; Philippe Herman; Victoria Murday; Patricia Niccoli-Sire; Janice L Pasieka; Vincent Rohmer; Kathy Tucker; Xavier Jeunemaitre; Deborah J Marsh; Pierre-François Plouin; Bruce G Robinson
Journal:  J Clin Endocrinol Metab       Date:  2005-11-29       Impact factor: 5.958

4.  Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations.

Authors:  Hartmut P H Neumann; Christian Pawlu; Mariola Peczkowska; Birke Bausch; Sarah R McWhinney; Mihaela Muresan; Mary Buchta; Gerlind Franke; Joachim Klisch; Thorsten A Bley; Stefan Hoegerle; Carsten C Boedeker; Giuseppe Opocher; Jörg Schipper; Andrzej Januszewicz; Charis Eng
Journal:  JAMA       Date:  2004-08-25       Impact factor: 56.272

Review 5.  Genomic imprinting and environment in hereditary paraganglioma.

Authors:  Bora E Baysal
Journal:  Am J Med Genet C Semin Med Genet       Date:  2004-08-15       Impact factor: 3.908

6.  Role of rapid sequence whole-body MRI screening in SDH-associated hereditary paraganglioma families.

Authors:  Kory W Jasperson; Wendy Kohlmann; Amanda Gammon; Heidi Slack; Luke Buchmann; Jason Hunt; Anne C Kirchhoff; Henry Baskin; Akram Shaaban; Joshua D Schiffman
Journal:  Fam Cancer       Date:  2014-06       Impact factor: 2.375

7.  Tumor risks and genotype-phenotype-proteotype analysis in 358 patients with germline mutations in SDHB and SDHD.

Authors:  Christopher J Ricketts; Julia R Forman; Eleanor Rattenberry; Nicola Bradshaw; Fiona Lalloo; Louise Izatt; Trevor R Cole; Ruth Armstrong; V K Ajith Kumar; Patrick J Morrison; A Brew Atkinson; Fiona Douglas; Steve G Ball; Jackie Cook; Umasuthan Srirangalingam; Pip Killick; Gail Kirby; Simon Aylwin; Emma R Woodward; D Gareth R Evans; Shirley V Hodgson; Vicky Murday; Shern L Chew; John M Connell; Tom L Blundell; Fiona Macdonald; Eamonn R Maher
Journal:  Hum Mutat       Date:  2010-01       Impact factor: 4.878

Review 8.  International consensus on initial screening and follow-up of asymptomatic SDHx mutation carriers.

Authors:  Laurence Amar; Karel Pacak; Olivier Steichen; Scott A Akker; Simon J B Aylwin; Eric Baudin; Alexandre Buffet; Nelly Burnichon; Roderick J Clifton-Bligh; Patricia L M Dahia; Martin Fassnacht; Ashley B Grossman; Philippe Herman; Rodney J Hicks; Andrzej Januszewicz; Camilo Jimenez; Henricus P M Kunst; Dylan Lewis; Massimo Mannelli; Mitsuhide Naruse; Mercedes Robledo; David Taïeb; David R Taylor; Henri J L M Timmers; Giorgio Treglia; Nicola Tufton; William F Young; Jacques W M Lenders; Anne-Paule Gimenez-Roqueplo; Charlotte Lussey-Lepoutre
Journal:  Nat Rev Endocrinol       Date:  2021-05-21       Impact factor: 43.330

Review 9.  Radiological Surveillance Screening in Asymptomatic Succinate Dehydrogenase Mutation Carriers.

Authors:  Nicola Tufton; Anju Sahdev; Scott A Akker
Journal:  J Endocr Soc       Date:  2017-06-06

10.  Incomplete penetrance of a novel SDHD variation causing familial head and neck paraganglioma.

Authors:  Martin Koenighofer; Thomas Parzefall; Alexandra Frohne; Elisabeth Frei; Christian Schoefer; Franco Laccone; Patricia Feil; Klemens Frei; Trevor Lucas
Journal:  Clin Otolaryngol       Date:  2021-05-05       Impact factor: 2.597

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.